drugset / Trial / NCT01593124

Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation

NCT01593124

Phase 2 Completed 20 enrolled CONRAD
RandomizedCrossoverOpen-labelBasic science

Summary

This study investigates the response of vaginal and cervical tissue after exposure to three vaginal products: hydroxyethyl cellulose (HEC) placebo, nonoxynol-9 (N9) and imiquimod (IMQ) cream.

Timeline

Start
2012-05
Primary completion
2013-04
Completion
2013-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Imiquimod Other / unclassified Other
Comparator Nonoxynol-9 Small molecule 4 % Other

Indications